1.64
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
8.40%
3.328
|
3.633 | 3.103 | 3.643 | 3.752 |
Operating Income/Loss |
3.92%
-6.226
|
-6.48 | -5.213 | -6.024 | -6.983 |
Income/Loss From Continuing Operations Before Tax |
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
Income/Loss From Continuing Operations After Tax |
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
|
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
49.39%
0.7381
|
1.4585 | 10.55 | 3.5199 | 0.6867 |
Diluted Average Shares |
49.39%
0.7381
|
1.4585 | 10.55 | 3.5199 | 0.6867 |
Basic Earnings Per Share |
91.34%
-8.40
|
-4.39 | -0.48 | -1.67 | -9.95 |
Diluted Earnings Per Share |
91.34%
-8.40
|
-4.39 | -0.48 | -1.67 | -9.95 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):